Effect of cabergoline alginate nanocomposite on the transgenic Drosophila melanogaster model of Parkinson’s disease-Reference-Cited by-同舟云学术

Effect of cabergoline alginate nanocomposite on the transgenic Drosophila melanogaster model of Parkinson’s disease

Published:2018-10-02 Issue:9 Volume:28 Page:699-708
ISSN:1537-6516
Container-title:Toxicology Mechanisms and Methods
language:en
Short-container-title:Toxicology Mechanisms and Methods

Author:

Khanam Saba¹,Naz Falaq¹,Ali Fahad¹,Smita Jyoti Rahul¹,Fatima Ambreen¹,Khan Wasi²,Singh Braj Raj³,Naqvi A. H.⁴,Siddique Yasir Hasan¹

Affiliation:

1. Department of Zoology, Section of Genetics, Drosophila Transgenic Laboratory, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, Uttar Pradesh, India;

2. Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh, India;

3. TERI-Deakin Nanobiotechnology Centre, TERI Gram, The Energy and Resources Institute, GualPahari, Gurgaon, Haryana, India;

4. Interdisciplinary Nanotechnology Centre, Aligarh Muslim University, Aligarh, India

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15376516.2018.1502386

Reference64 articles.

1. The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development

2. Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease

3. Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

4. Role of dopamine receptor agonists in the treatment of early Parkinson's disease

5. Design and Comparison of Wallace Multiplier Based on Symmetric Stacking and High Speed counters

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders;CNS & Neurological Disorders - Drug Targets;2024-10

2. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases;Current Drug Delivery;2024-08

3. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities;Current Pharmaceutical Design;2022-09

4. Drosophila: A Model to Study the Pathogenesis of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2022-04

5. Development of medical polymers for applications in neurological disorders;Polymeric Biomaterials for Healthcare Applications;2022